J. Safra Sarasin Holding AG lowered its stake in AMETEK, Inc. (NYSE:AME – Free Report) by 55.4% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,640 shares of the technology company’s stock after selling 5,758 shares during the quarter. J. Safra Sarasin Holding AG’s holdings in AMETEK were worth $872,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds also recently made changes to their positions in AME. Sivia Capital Partners LLC purchased a new position in AMETEK during the second quarter valued at approximately $295,000. GC Wealth Management RIA LLC purchased a new position in shares of AMETEK during the 2nd quarter valued at $614,000. ASR Vermogensbeheer N.V. boosted its holdings in AMETEK by 42.2% in the 2nd quarter. ASR Vermogensbeheer N.V. now owns 162,555 shares of the technology company’s stock worth $29,415,000 after buying an additional 48,207 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its stake in AMETEK by 35.2% in the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 30,942 shares of the technology company’s stock worth $5,599,000 after buying an additional 8,064 shares in the last quarter. Finally, Ameritas Advisory Services LLC bought a new stake in AMETEK during the second quarter valued at about $73,000. 87.43% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In related news, insider Thomas C. Marecic sold 14,310 shares of the stock in a transaction on Monday, December 15th. The stock was sold at an average price of $202.11, for a total transaction of $2,892,194.10. Following the sale, the insider owned 42,589 shares in the company, valued at approximately $8,607,662.79. This represents a 25.15% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP Thomas M. Montgomery sold 6,388 shares of the firm’s stock in a transaction on Monday, December 22nd. The stock was sold at an average price of $205.05, for a total value of $1,309,859.40. Following the completion of the sale, the vice president owned 22,116 shares of the company’s stock, valued at approximately $4,534,885.80. This represents a 22.41% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 163,378 shares of company stock valued at $32,471,654. 0.57% of the stock is currently owned by company insiders.
AMETEK Price Performance
AMETEK (NYSE:AME – Get Free Report) last posted its earnings results on Thursday, October 30th. The technology company reported $1.89 earnings per share for the quarter, topping analysts’ consensus estimates of $1.76 by $0.13. The firm had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.81 billion. AMETEK had a net margin of 20.50% and a return on equity of 16.66%. The business’s quarterly revenue was up 10.8% on a year-over-year basis. During the same period in the previous year, the firm posted $1.66 EPS. Sell-side analysts forecast that AMETEK, Inc. will post 7.15 EPS for the current fiscal year.
AMETEK Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, December 19th. Shareholders of record on Friday, December 5th were paid a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Friday, December 5th. AMETEK’s payout ratio is presently 19.56%.
Wall Street Analysts Forecast Growth
AME has been the topic of several recent analyst reports. DA Davidson lifted their target price on AMETEK from $235.00 to $240.00 and gave the company a “buy” rating in a research note on Monday, December 8th. Deutsche Bank Aktiengesellschaft started coverage on shares of AMETEK in a report on Wednesday, January 21st. They set a “buy” rating and a $271.00 price objective for the company. Melius Research set a $235.00 target price on shares of AMETEK in a report on Monday, January 5th. Truist Financial raised their target price on shares of AMETEK from $219.00 to $229.00 and gave the company a “buy” rating in a research note on Wednesday, October 8th. Finally, Robert W. Baird increased their price objective on shares of AMETEK from $198.00 to $204.00 and gave the company a “neutral” rating in a report on Monday, November 3rd. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, AMETEK has an average rating of “Moderate Buy” and a consensus target price of $229.82.
View Our Latest Stock Analysis on AMETEK
AMETEK Profile
AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.
The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.
Featured Articles
- Five stocks we like better than AMETEK
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.
